5-(Pyrimidin-2-ylthio)furan-2-carbaldehyde

Catalog No. :
ACJFXT397
CAS No. :
57603-82-4
Molecular Formula :
C9H6N2O2S
Molecular Weight :
206.23

IUPAC Name:5-(pyrimidin-2-ylthio)furan-2-carbaldehyde

5-(Pyrimidin-2-ylthio)furan-2-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$163.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Pyrimidin-2-ylthio)furan-2-carbaldehyde
IUPAC Name5-(pyrimidin-2-ylthio)furan-2-carbaldehyde
MDL No.MFCD02068936
Molecular FormulaC9H6N2O2S
Molecular Weight206.23
SMILESO=CC1=CC=C(SC2=NC=CC=N2)O1
InChI KeyBVGQOPQJOBCDBN-UHFFFAOYSA-N
Synonym5-(PYRIMIDIN-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE;5-(pyrimidin-2-ylthio)-2-furaldehyde(SALTDATA: FREE);5-(2-PYRIMIDINYLTHIO)-2-FURALDEHYDE;CHEMBRDG-BB 4302971;5-(PYRIMIDIN-2-YLTHIO)-2-FURALDEHYDE;2-Furancarboxaldehyde, 5-(2-pyrimidinylthio)-;5-(Pyrimidin-2-ylthio)furan-2-carbaldehyde
CAS No.57603-82-4
PubChem CID1112170

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACJFXT397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRUXI465 route compound structure diagram
    ACRUXI4651899-24-7 In Stock
  2. Plus
  3. ACPMJA283 route compound structure diagram
    ACPMJA283131242-36-9 In Stock
  4. Then
  5. ACJFXT397 route product structure diagram
    ACJFXT39757603-82-4 In Stock
Inquiry

2. ACJFXT397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMHYF198 route compound structure diagram
    ACMHYF19821508-19-0 In Stock
  2. Plus
  3. ACPMJA283 route compound structure diagram
    ACPMJA283131242-36-9 In Stock
  4. Then
  5. ACJFXT397 route product structure diagram
    ACJFXT39757603-82-4 In Stock
Inquiry

Comments (0)